Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Phase Ib Study of Fruquintinib in 3rd Line mCRC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01975077
Recruitment Status : Completed
First Posted : November 3, 2013
Last Update Posted : February 17, 2020
Fudan University
Sun Yat-sen University
Information provided by (Responsible Party):
Hutchison Medipharma Limited

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2014
Actual Study Completion Date : October 2014